Iguana Healthcare Management as of Dec. 31, 2013
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 70 positions in its portfolio as reported in the December 2013 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amgen (AMGN) | 6.5 | $11M | 100k | 114.08 | |
Spdr S&p 500 Etf Tr option | 5.1 | $9.0M | 50k | 179.74 | |
Merck & Co (MRK) | 5.0 | $8.8M | 175k | 50.05 | |
Biogen Idec (BIIB) | 4.8 | $8.4M | 30k | 279.57 | |
Zimmer Holdings (ZBH) | 4.2 | $7.5M | 80k | 93.19 | |
Gilead Sciences (GILD) | 3.6 | $6.4M | 85k | 75.11 | |
Merck & Co Inc New option | 3.5 | $6.2M | 125k | 49.30 | |
iShares Russell 2000 Index (IWM) | 3.2 | $5.6M | 50k | 111.54 | |
Mylan | 2.8 | $5.0M | 115k | 43.40 | |
Celldex Therapeutics | 2.8 | $4.8M | 200k | 24.21 | |
CIGNA Corporation | 2.5 | $4.4M | 50k | 87.48 | |
Tornier N V | 2.5 | $4.4M | 250k | 17.44 | |
Amgen Inc option | 2.3 | $4.0M | 35k | 113.06 | |
Ligand Pharmaceuticals In (LGND) | 2.2 | $3.9M | 75k | 52.60 | |
Incyte Corporation (INCY) | 2.2 | $3.8M | 75k | 50.63 | |
Tornier Nv | 2.1 | $3.8M | 200k | 18.79 | |
Arthrocare | 2.1 | $3.8M | 100k | 37.62 | |
Covidien | 1.9 | $3.4M | 50k | 68.10 | |
Alkermes (ALKS) | 1.7 | $3.1M | 75k | 40.67 | |
ArthroCare Corporation | 1.7 | $3.0M | 75k | 40.24 | |
Forest Labs Inc option | 1.6 | $2.8M | 50k | 56.28 | |
Endologix | 1.6 | $2.8M | 160k | 17.44 | |
Neostem | 1.6 | $2.7M | 400k | 6.82 | |
Puma Biotechnology (PBYI) | 1.5 | $2.6M | 25k | 103.52 | |
EnteroMedics | 1.3 | $2.3M | 1.1M | 2.04 | |
InterMune | 1.3 | $2.2M | 150k | 14.73 | |
Wright Medical | 1.2 | $2.1M | 70k | 30.71 | |
Dex (DXCM) | 1.2 | $2.1M | 60k | 35.42 | |
Esperion Therapeutics (ESPR) | 1.2 | $2.1M | 150k | 13.74 | |
Aerie Pharmaceuticals | 1.1 | $2.0M | 113k | 17.96 | |
Sunshine Heart | 1.0 | $1.8M | 185k | 9.71 | |
Express Scripts Holding | 1.0 | $1.8M | 25k | 70.24 | |
Edwards Lifesciences (EW) | 0.9 | $1.6M | 25k | 65.76 | |
MiMedx (MDXG) | 0.9 | $1.6M | 180k | 8.74 | |
Quest Diagnostics Inc option | 0.9 | $1.5M | 25k | 60.88 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $1.5M | 20k | 74.30 | |
Agilent Technologies Inc C ommon (A) | 0.8 | $1.4M | 25k | 57.20 | |
Sarepta Therapeutics (SRPT) | 0.8 | $1.4M | 70k | 20.37 | |
Novadaq Technologies | 0.8 | $1.4M | 85k | 16.49 | |
NPS Pharmaceuticals | 0.8 | $1.4M | 45k | 30.36 | |
United Therapeutics Corp Cmn Stk cmn | 0.8 | $1.4M | 15k | 90.73 | |
AVANIR Pharmaceuticals | 0.8 | $1.3M | 400k | 3.36 | |
Celldex Therapeutics Inc cmn | 0.8 | $1.3M | 50k | 26.16 | |
Bruker Corporation (BRKR) | 0.7 | $1.3M | 65k | 19.77 | |
Impax Laboratories | 0.7 | $1.3M | 50k | 25.14 | |
Impax Laboratories Inc Cmn Stock cmn | 0.7 | $1.2M | 50k | 23.72 | |
Thoratec Corporation | 0.6 | $1.1M | 30k | 36.60 | |
Cyclacel Pharmaceuticals | 0.6 | $1.1M | 275k | 4.02 | |
Enanta Pharmaceuticals (ENTA) | 0.6 | $1.1M | 40k | 27.28 | |
CONMED Corporation (CNMD) | 0.6 | $1.1M | 25k | 42.52 | |
Array BioPharma | 0.6 | $1.0M | 200k | 5.01 | |
Cytokinetics (CYTK) | 0.6 | $975k | 150k | 6.50 | |
Medivation | 0.6 | $957k | 15k | 63.80 | |
Medicines Company cmn | 0.5 | $943k | 25k | 37.72 | |
Insulet Corporation (PODD) | 0.5 | $928k | 25k | 37.12 | |
Bruker Corp call | 0.5 | $930k | 50k | 18.60 | |
Zogenix | 0.5 | $860k | 250k | 3.44 | |
Infinity Pharmaceuticals Inc. cmn | 0.4 | $725k | 50k | 14.50 | |
Supernus Pharmaceuticals | 0.4 | $714k | 100k | 7.14 | |
DepoMed | 0.4 | $688k | 65k | 10.58 | |
Chimerix (CMRX) | 0.4 | $680k | 45k | 15.11 | |
Edwards Lifesciences Corp option | 0.4 | $649k | 10k | 64.90 | |
Sangamo Biosciences Inc Cmn Stk cmn | 0.4 | $639k | 50k | 12.78 | |
Amicus Therapeutics (FOLD) | 0.3 | $623k | 265k | 2.35 | |
Solta Medical | 0.3 | $516k | 175k | 2.95 | |
INSTRS INC Stemcells | 0.3 | $492k | 400k | 1.23 | |
Cadence Pharmaceuticals | 0.3 | $453k | 50k | 9.06 | |
Tesaro | 0.2 | $424k | 15k | 28.27 | |
Amarin Corp Plc option | 0.2 | $291k | 150k | 1.94 | |
Accelr8 Technology | 0.2 | $305k | 25k | 12.20 |